ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,815
0,33%
Bitcoin
57 406,70
-1,43%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Theseus Pharmaceuticals Inc (THRX)

  7. Theseus Pharmaceuticals Inc (THRX) Actualités

THRX Theseus Pharmaceuticals Inc

4,06
0,00 (0,00%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Theseus Pharmaceuticals Inc THRX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 4,06 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,06 4,06
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/2/202415:00EDGAR2Form 15-12G - Securities registration termination [Section..
16/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202420:26EDGAR2Form S-8 POS - Securities to be offered to employees in..
14/2/202420:22EDGAR2Form POS AM - Post-Effective amendments for registration..
14/2/202416:44EDGAR2Form 8-K - Current report
14/2/202416:35EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
14/2/202414:30PRNUSTheseus Pharmaceuticals Announces Closing of Tender Offer
13/2/202418:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202423:21EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
07/2/202423:15EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
30/1/202414:52EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
30/1/202414:23EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
30/1/202414:00BWConcentra Announces Calculation of Additional Price Per..
10/1/202415:47EDGAR2Form SC 14D9 - Solicitation, recommendation statements
10/1/202414:51EDGAR2Form SC TO-T - Tender offer statement by Third Party
22/12/202312:52EDGAR2Form SC14D9C - Written communication relating to third party..
22/12/202312:36EDGAR2Form 8-K - Current report
22/12/202312:30PRNUSTheseus Pharmaceuticals Enters into Agreement to Be Acquired..
04/12/202312:30EDGAR2Form 8-K - Current report
27/11/202312:37EDGAR2Form 8-K - Current report
27/11/202312:30PRNUSTheseus Pharmaceuticals Confirms Receipt of Unsolicited..
24/11/202322:23EDGAR2Form SC 13D/A - General statement of acquisition of..
17/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202313:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
13/11/202322:05PRNUSTheseus Pharmaceuticals Announces Process to Explore..
07/11/202322:05PRNUSTheseus Pharmaceuticals to Participate in the Stifel 2023..
07/11/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202321:13EDGAR2Form 8-K - Current report
10/8/202313:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:05EDGAR2Form 8-K - Current report
10/8/202313:00PRNUSTheseus Pharmaceuticals Announces Business Highlights and..
19/7/202320:41EDGAR2Form SC 13D/A - General statement of acquisition of..
14/7/202313:51IHMARKETNEWSFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase,..
13/7/202322:08EDGAR2Form 8-K - Current report
13/7/202322:05PRNUSTheseus Pharmaceuticals to Discontinue Enrollment in Phase..
31/5/202313:00PRNUSTheseus Pharmaceuticals to Participate in the Jefferies..
25/5/202323:01PRNUSTheseus Pharmaceuticals Reports Initial Dose Escalation Data..
11/5/202313:00PRNUSTheseus Pharmaceuticals Announces Business Highlights and..

Dernières Valeurs Consultées

NASDAQ
THRX
Theseus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés